Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank27
3Y CAGR-4.5%
5Y CAGR-12.0%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-4.5%/yr
vs +1.9%/yr prior
5Y CAGR
-12.0%/yr
Recent acceleration
Acceleration
-6.4pp
Decelerating
Percentile
P27
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$49.69M-20.4%
2024$62.45M+4.7%
2023$59.67M+4.6%
2022$57.05M-32.2%
2021$84.17M-10.5%
2020$94.05M+53.1%
2019$61.41M+16.0%
2018$52.93M-18.6%
2017$65.01M+188.5%
2016$22.54M-